Literature DB >> 30312253

Is Magnetically Controlled Growing Rod the Game Changer in Early-onset Scoliosis? A Preliminary Report.

Senol Bekmez1, Ayaz Afandiyev2, Ozgur Dede3, Eda Karaismailoğlu4, Halil G Demirkiran2, Muharrem Yazici2.   

Abstract

BACKGROUND: Magnetically controlled growing rod (MCGR) concept was introduced with the premise of minimizing the repetitive lengthening surgeries, which is default in traditional growing rod (TGR) treatment for early-onset scoliosis (EOS). Despite good radiographic outcomes, previous studies did not compare identical patient groups in terms of etiology and deformity characteristics; therefore, a true comparison of the MCGR and TGR is essential. This study was designed to compare 2 techniques in terms of clinical, radiologic, and health-related quality of life (HRQoL) outcomes.
METHODS: Patients with long sweeping congenital curves who underwent convex growth arrest and concave distraction (with TGR or MCGR) were retrospectively reviewed. Instrumented all-posterior convex growth arrest and concave distraction with growing rod technique were performed. Demographic parameters, follow-up time, number of lengthening procedures, radiographic parameters, number of unplanned surgeries, and complications were recorded. The Early-Onset Scoliosis Questionnaire (EOSQ-24) was used to evaluate HRQoL outcomes.
RESULTS: A total of 20 patients were included (10 MCGR, 10 TGR). No significant differences were found with regard to average age, follow-up time, radiographic parameters, or complications. Overall surgery per patient including index surgery, and planned and unplanned procedures were significantly lower in the MCGR group (8.8 vs. 1.3) (P=0.01). No patient in either group had graduated from growing rod treatment. HRQoL analysis revealed no significant difference between the 2 groups in any specific domain or in the overall score of the EOSQ-24.
CONCLUSIONS: Although equally effective in controlling the deformity and superior in reducing the number of surgeries with comparable complication rates, MCGR does not offer any significant improvement in HRQoL outcomes or the overall complication rate. Despite the obvious advantages, according to this preliminary report, the current technology and technique of MCGR may not be sufficient to be the long-awaited "game changer" in the treatment of EOS.

Entities:  

Mesh:

Year:  2019        PMID: 30312253     DOI: 10.1097/BPO.0000000000001268

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  Outcomes of MCGR at > 3 year average follow-up in severe scoliosis: who undergoes elective revision vs UPROR?

Authors:  Michelle Cameron Welborn; Daniel Bouton
Journal:  Spine Deform       Date:  2021-10-14

Review 2.  Re-evaluating consensus and uncertainty among treatment options for early onset scoliosis: a 10-year update.

Authors:  Hiroko Matsumoto; Adam N Fano; Theodore Quan; Behrooz A Akbarnia; Laurel C Blakemore; John M Flynn; David L Skaggs; John T Smith; Brian D Snyder; Paul D Sponseller; Richard E McCarthy; Peter F Sturm; David P Roye; John B Emans; Michael G Vitale
Journal:  Spine Deform       Date:  2022-08-10

3.  Definitive fusions are better than growing rod procedures for juvenile patients with cerebral palsy and scoliosis: a prospective comparative cohort study.

Authors:  Arun R Hariharan; Suken A Shah; Paul D Sponseller; Burt Yaszay; Michael P Glotzbecker; George H Thompson; Patrick J Cahill; Tracey P Bastrom
Journal:  Spine Deform       Date:  2022-09-26

4.  Health-related quality of life in early-onset-scoliosis patients treated with growth-friendly implants is influenced by etiology, complication rate and ambulatory ability.

Authors:  Anna K Hell; Lena Braunschweig; Jennifer Behrend; Heiko M Lorenz; Konstantinos Tsaknakis; Urs von Deimling; Kiril Mladenov
Journal:  BMC Musculoskelet Disord       Date:  2019-12-07       Impact factor: 2.362

5.  Smaller Intervertebral Disc Volume and More Disc Degeneration after Spinal Distraction in Scoliotic Children.

Authors:  Sebastian Lippross; Paul Girmond; Katja A Lüders; Friederike Austein; Lena Braunschweig; Stefan Lüders; Konstantinos Tsaknakis; Heiko M Lorenz; Anna K Hell
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.